SCHEMBL31093149

SCHEMBL31093149

C=CC(=C)C(=C)CCn1c2ccccc2c2ccccc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.56
FABP4 P15090 3/20 0.53
FABP5 Q01469 3/20 0.53
FABP3 P05413 1/20 0.53
HDAC6 Q9UBN7 4/20 0.49
FNTA P49354 2/20 0.43
FNTB P49356 2/20 0.43
CYP1A2 P05177 3/20 0.42
CYP2C19 P33261 3/20 0.42
HDAC1 Q13547 3/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41
BACE1 P56817 2/20 0.41
ALDH1A1 P00352 3/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C9 P11712 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31093102 0.83 FABP4 (0.56) KDM4EFABP4FABP5FABP3HDAC6
SCHEMBL12110662 0.78 FABP4 (0.64) KDM4EFABP4FABP5FABP3HDAC6
SCHEMBL1246435 0.78 FABP4 (0.69) KDM4EFABP4FABP5FABP3HDAC6
SCHEMBL17841726 0.75 FABP4 (0.59) KDM4EFABP4FABP5FABP3HDAC6
SCHEMBL31093049 0.74 FABP4 (0.50) KDM4EFABP4FABP5FABP3HDAC6
SCHEMBL31092935 0.73 LMNA (0.59) CYP1A2CYP2C19KMT2ALMNABACE1
SCHEMBL31093115 0.72 FABP4 (0.61) KDM4EFABP4FABP5FABP3HDAC6
SCHEMBL11814735 0.72 KDM4E (0.53) KDM4EFABP4FABP5FABP3HDAC6
SCHEMBL3322057 0.72 KDM4E (1.00) KDM4EFABP4FABP5FABP3HDAC6
SCHEMBL9768532 0.71 CYP1A2 (0.70) KDM4EFABP4FABP5FABP3HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240287009-A1 AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME INFINEUM INTERNATIONAL LIMITED (GB) 2024-08-29 US claimed
EP-4410772-A2 AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME Infineum International Limited (GB) 2024-08-07 EP claimed
CN-118440229-A Amine functional monomers and methods of making the same 英菲诺姆国际有限公司 2024-08-06 CN claimed
US-20250250379-A1 AMINE CONTAINING POLYMER COMPOSITIONS AND USES THEREOF INFINEUM INTERNATIONAL LIMITED (US) 2025-08-07 US disclosed
EP-4596661-A1 AMINE CONTAINING POLYMER COMPOSITIONS AND USES THEREOF Infineum International Limited (GB) 2025-08-06 EP disclosed
US-20240287009-A1 AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME INFINEUM INTERNATIONAL LIMITED (GB) 2024-08-29 US disclosed
EP-4410772-A2 AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME Infineum International Limited (GB) 2024-08-07 EP disclosed
CN-118440229-A Amine functional monomers and methods of making the same 英菲诺姆国际有限公司 2024-08-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240287009-A1 AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME AMD1, HNMT, MAT1A KDM4E 797/4885FABP4 4374/4885FABP5 4684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.